Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (1)
  • 2025 (9)
  • 2024 (11)
  • 2023 (13)
  • 2022 (6)
  • 2021 (3)
  • 2019 (4)

Subject

  • Drug Trafficking (1039)
  • OCDETF/Task Force (391)
  • Guns/Weapons (290)
  • Fake Pills (120)
  • Diversion Division (45)
  • Gangs (42)
  • Money Laundering (38)
  • Take Back Day (29)
  • HIDTA (27)
  • Outreach/Drug Prevention (26)
  • Arrests/Convictions - Major (23)
  • Public and Media Affairs - also see Congressional Affairs (17)
  • Synthetic drugs (16)
  • Major Law Enforcement Operation (15)
  • Pharmaceuticals/Pharmacists/Physicians (14)
  • Congressional Affairs (12)
  • Fentanyl Awareness (12)
  • Press Conferences (12)
  • Counterfeit Pills (11)
  • Task Forces/Task Force Officers (11)
  • One Pill Can Kill (10)
  • Red Ribbon (10)
  • Guilty Plea (9)
  • Prevention/Education - DEA websites GSAD, JTT etc (9)
  • Overdose (8)
  • Seizures (Drugs/Property) (5)
  • Extraditions (4)
  • Intergovernmental Affairs (4)
  • International/Foreign Operations (4)
  • Narcoterrorism (4)
  • Critical Incident (3)
  • Fentanyl Free America (3)
  • Campaigns (2)
  • Scam Calls (2)
  • Terrorism (2)
  • Dark Web- Internet Trafficking (1)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Other (1)
  • Prescription Drugs (47)

Drug Name

  • Oxycodone (16)
  • Fentanyl (7)
  • Methamphetamine (3)
  • Opioids (3)
  • Cocaine (2)
  • Benzodiazepines (1)
  • GHB (1)
  • Heroin (1)
  • Hydromorphone (1)
  • Marijuana (Cannabis) (1)
  • Marijuana Concentrates (1)

Field Division

  • Washington, DC (45)
  • St. Louis (39)
  • New York (35)
  • Seattle (25)
  • Atlanta (19)
  • Miami (19)
  • Chicago (16)
  • Dallas (15)
  • New Jersey (15)
  • El Paso (14)
  • Houston (12)
  • San Francisco (12)
  • Louisville (10)
  • Los Angeles (9)
  • Omaha (9)
  • New Orleans (8)
  • Phoenix (6)
  • Rocky Mountain (6)
  • San Diego (6)
  • Detroit (3)
  • Philadelphia (1)
  • New England (24)
  • Sede (23)
Clear All Results
47 Results - Showing 1 to 10
PRESS RELEASE

DEA Releases 2026 Aggregate Production Quotas

WASHINGTON – This week the U.S. Drug Enforcement Administration released the established aggregate production quotas (APQ) for schedule I and II controlled substances and assessment of annual needs (AAN) for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine for 2026. “DEA is committed to ensuring that patients can access the...
PRESS RELEASE

DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care

WASHINGTON – The U.S. Drug Enforcement Administration, in partnership with the Department of Health and Human Services (HHS), has issued a Fourth Temporary Extension of the COVID-19 Telemedicine Flexibilities for the Prescription of Controlled Medications , extending the current telemedicine flexibilities through December 31, 2026. Under these telemedicine flexibilities, DEA-registered...
PRESS RELEASE

DEA Hosts the 29th National Prescription Drug Take Back Day on Saturday, October 25th

WASHINGTON –The Drug Enforcement Administration, in collaboration with nearly 4,000 law enforcement partners across the country, will host the 29th National Prescription Drug Take Back Day this Saturday, October 25, from 10 a.m. to 2 p.m. At nearly 4,000 collection sites throughout the United States, DEA’s National Prescription Drug Take...
PRESS RELEASE

Three Charged with Trafficking Narcotics in the Naugatuck Valley

HARTFORD, Conn. - Marc H. Silverman, Acting United States Attorney for the District of Connecticut, Anish Shukla, Acting Special Agent in Charge of the New Haven Division of the Federal Bureau of Investigation, Stephen P. Belleau, Acting Special Agent in Charge of the Drug Enforcement Administration for New England, announced...
PRESS RELEASE

Carver Man Sentenced to More Than Two Years in Prison for Oxycodone Conspiracy

BOSTON – A Carver man has been sentenced in federal court in Boston for his involvement in an oxycodone conspiracy. Michael Atwood, 37, was sentenced by U.S. District Court Judge Denise J. Casper to 35 months in prison, to be followed by three years of supervised release. In November 2024...
PRESS RELEASE

DEA Releases 2025 National Drug Threat Assessment

WASHINGTON – The U.S. Drug Enforcement Administration today announced the release of the 2025 National Drug Threat Assessment (NDTA), DEA’s comprehensive review of the threats posed to the United States by deadly illicit drugs and the violent domestic and international drug trafficking organizations responsible for producing and trafficking the drugs...
PRESS RELEASE

DEA Safely Disposes of 620,000 Pounds of Unused Medications on 28th National Prescription Drug Take Back Day

WASHINGTON – DEA and nearly 4,500 law enforcement agencies joined forces last month to dispose of more than 620,000 pounds of unneeded and expired medications in an effort to prevent drug misuse and abuse. The spring collection event marked DEA’s 28th National Prescription Drug Take Back Day. Since its inception...
PRESS RELEASE

Texas Man Sentenced to More Than Five Years in Prison for Oxycodone Conspiracy and Structuring Cash Transactions

BOSTON – A Texas man has been sentenced in federal court in Boston for a drug conspiracy involving the distribution of oxycodone pills across Southeastern Massachusetts and beyond. Christan Russell, 33, of Tomball, Texas was sentenced by U.S. District Court Judge Denise J. Casper to 70 months in prison, to...
PRESS RELEASE

Hartford Man Pleads Guilty to Oxycodone Distribution and Gun Possession Offenses

HARTFORD, Conn. - Marc H. Silverman, Acting United States Attorney for the District of Connecticut, announced that ANGEL BENITEZ, 38, of Hartford, pleaded guilty before U.S. District Judge Vernon D. Oliver in Hartford to drug distribution and firearm possession offenses. According to court documents and statements made in court, a...
PRESS RELEASE

DEA Announces Three New Telemedicine Rules that Continue to Open Access to Telehealth Treatment while Protecting Patients

WASHINGTON – The U.S. Drug Enforcement Administration is announcing three new rules to make permanent some temporary telemedicine flexibilities established during the COVID-19 public health emergency while also establishing new patient protections. In developing these rules, DEA has focused on the patient to ensure telemedicine is accessible for medical care...

Paginación

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster